MagForce AG (MF6) - Product Pipeline Analysis, 2017 Update

  • ID: 4400027
  • Company Profile
  • 32 pages
  • GlobalData
1 of 5

MagForce AG (MagForce) is a medical device company that offers nanotechnology-based cancer treatment. The company offers treatment for brain tumor and cancer diseases. It provides products such as NanoActivator, NanoTherm, NanoPlan and NanoTherm Therapy. MagForce’s product NanoActivator creates a magnetic field that can be used to treat tumors in all areas of the body and NanoTherm is a liquid that reacts to the presence of magnetic field. The company offers products which used in the treatment of prostate cancer, pancreatic cancer, esophageal cancer and glioblastoma. It operates through therapy centers located in university hospitals Berlin, and the university hospitals Munster, Kiel, Cologne and Frankfurt, among others. The company has its presence in Berlin, Munich, and the US. MagForce is headquartered in Berlin, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company MagForce AG
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 5
  • MagForce AG Company Overview
  • MagForce AG Company Snapshot
  • MagForce AG Pipeline Products and Ongoing Clinical Trials Overview
  • MagForce AG - Pipeline Analysis Overview
  • MagForce AG - Key Facts
  • MagForce AG - Major Products and Services
Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • Heidelberg University Hospital
  • German Cancer Research Center
  • Boehringer Ingelheim GmbH
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown